您好,欢迎光临世界标品! 登录 注册(订药物标准品请用邮件联系我们)

SCITEK INTERNATIONAL (H.K.) LIMITED
Email: sciteck.hongkong@gmail.com
 

当前本网站药物产品种数共 8524 处方药 8148 非处方药 269 保健品/医疗用具 107

世界标品医药目录搜索(中英文):
世界各国官方药品目录搜索(英文):
世界标品医药知识搜索(中英文):

联系方式
国内客服电话:
国际免费电话:

咨询邮箱:
scimed.shanghai@shijiebiaopin.com
info@shijiebiaopin.com
pharmacy.shijiebiaopin1@gmail.com
pharmacy.shijiebiaopin2@gmail.com

  药店国别: 澳大利亚药房
产地国家: 澳大利亚
所属类别: 心血管系统药物->抗心绞痛药物
处方药:处方药
包装规格: (75毫克/100毫克)/片 30片/盒
计价单位:
  点击放大  
生产厂家中文参考译名:
赛诺菲安万特
生产厂家英文名:
Sanofi Aventis
该药品相关信息网址1:
http://www.medicamentosplm.com/productos/36787_210.htm
该药品相关信息网址2:
http://www.china.mims.com/Singapore/drug/info/CoPlavix/CoPlavix%20film-coated%20tab?q=Clopidogrel&type=brief
原产地英文商品名:
COPLAVIX (75mg/100mg)/tab 30tabs/box
原产地英文药品名:
CLOPIDOGREL/ASPIRIN
中文参考商品译名:
COPLAVIX (75毫克/100毫克)/片 30片/盒
中文参考药品译名:
氯吡格雷/阿司匹林
原产地国家批准上市年份:
0000/00/00
英文适应病症1:
Coronary syndrome
英文适应病症2:
Angina
英文适应病症3:
Myocardial infarction
英文适应病症4:
Anticoagulant
英文适应病症5:
Thrombolysis
临床试验期:
完成
中文适应病症参考翻译1:
冠脉综合征
中文适应病症参考翻译2:
心绞痛
中文适应病症参考翻译3:
心肌梗死
中文适应病症参考翻译4:
抗凝血
中文适应病症参考翻译5:
溶栓
药品信息:

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(201232118491430.PDF,201232118490522.PDF)的“原文Priscribing Information”为准
---------------------------------------------------------------
部分中文CoPlavix处方资料(仅供参考)

Clopidogrel,中文名叫:氯吡格雷。
是个抗血凝的药物。
血小板的凝聚,最后就会造成血液凝结,形成血栓。
怎么形成这个抗血凝聚的作用呢?就是氯吡格雷会阻断腺苷二磷酸和血小板的结合,因此阻止血栓的产生。

Aspirin:阿司匹林是一种非甾体抗炎药,也叫乙酰水杨酸,可以解热镇痛,抗炎抗风湿治疗痛风,还可以抗血栓,现在已被广泛应用于心血管疾病的一级预防和二级预防。

CoPlavix - Concise Prescribing Information
Manufacturer:
sanofi-aventis 

Distributor:Zuellig 

Contents:Clopidogrel 75 mg, acetylsalicylic acid 100 mg

Indications:Prevention of atherothrombotic events in patients suffering from non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave MI); ST segment elevation acute MI in medically treated patients eligible for thrombolytic therapy.

Dosage:Adult & elderly 1 tab as single daily dose. Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave MI) Initially 300 mg as single dose of clopidogrel & an appropriate dose of ASA, then CoPlavix 1 tab once daily for 12 mth. ST segment elevation acute MI Therapy should be started as soon as symptoms start, then continued for at least 4 wk.

Overdosage:View CoPlavix overdosage for action to be taken in the event of an overdose.

Administration:May be taken with or without food (May be taken w/ meals to reduce GI discomfort.).

Contraindications:Severe renal & hepatic impairment, active pathological bleeding eg peptic ulcer/intracranial haemorrhage; allergy to NSAID, patients w/ asthma, rhinitis & nasal polyps; history of peptic ulcer, haemophilia & other bleeding disorders. Galactose intolerance, Lapp lactase deficiency/glucose-galactose malabsorption.

Special Precautions:Monitor blood cell count. Patient at risk of increased bleeding from trauma, surgery or other pathological conditions. Discontinue use 7 days prior to surgery. Lesions w/ a propensity to bleed. Recent transient ischaemic attack or stroke. Mild to moderate renal impairment. Moderate hepatic disease. Asthma or allergic disorders, gout, HTN; history of peptic ulcer/gastroduodenal hemorrhage/minor upper GI symptoms. Pregnancy & lactation. Childn.

Adverse Drug Reactions:GI bleeding, purpura/bruising & epistaxis. Severe neutropenia & thrombocytopenia. Diarrhoea, abdominal pain & dyspepsia.
View ADR Monitoring Form

Drug Interactions:Oral anticoagulants, glycoprotein IIb/IIIa inhibitors, heparin, thrombolytics, NSAIDs, uricosurics, methotrexate, ACE inhibitors, acetazolamide, anticonvulsants, β-blockers, diuretics & oral hypoglycemic agents.
View more drug interactions with CoPlavix

Storage:View CoPlavix storage conditions for details to ensure optimal shelf-life.

Description:View CoPlavix description for details of the chemical structure and excipients (inactive components).

Mechanism of Action:View CoPlavix mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class:Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

ATC Classification:B01AC04 - clopidogrel ; Belongs to the class of platelet aggregation inhibitors excluding heparin. Used in the treatment of thrombosis. 

Poison Schedule:POM

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(201232118491430.PDF,201232118490522.PDF)的“原文Priscribing Information”为准
---------------------------------------------------------------

更新日期: 2013-10-20
附件:
 
调控比例: 100%
订购表单下载
Copyrights © 2010,2011,2012 www.ShiJieBiaoPin.com, Inc., All rights Reserved www.ShiJieBiaoPin.com, Inc.
客服工作时间:太平洋时间18:00-24:00
国内客服电话:     国际免费电话:
友情提示:以上电话为免费电话,无需您承担任何费用,世界标品提供中文客服,请您放心拨打!
电子邮箱:sciteck.hongkong@gmail.com, 15901965168@163.com